Skip to main content
Erschienen in: Obesity Surgery 11/2016

17.03.2016 | Original Contributions

The Effects of One-Anastomosis Gastric Bypass on Glucose Metabolism in Goto-Kakizaki Rats

verfasst von: Lorea Zubiaga, Rafael Abad, Jaime Ruiz-Tovar, Pablo Enriquez, Juan Antonio Vílchez, Mireia Calzada, José Antonio Pérez De Gracia, Mervyn Deitel

Erschienen in: Obesity Surgery | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The improvement in glucose metabolism after bariatric surgery is well established. The aim of this study was to investigate the hormones and glycemic control in diabetes after a one-anastomosis gastric bypass (OAGB) variant in an animal model of non-obese type 2 diabetes mellitus.

Methods

Thirty-six Goto-Kakizaki rats were randomly assigned to undergo one of the following procedures: OAGB (18 rats) or sham intervention (18 rats). Each group was subdivided into three additional groups according to the time of surgery (early—12 weeks; intermediate—16 weeks; and late—20 weeks). Weight, fasting glycemia, glucose tolerance test (OGTT), and hormone levels (glucagon, insulin, glucagon-like peptide-1 [GLP-1], and glucose-dependent insulinotropic peptide [GIP]) were measured.

Results

All rats maintained their weight. The OGTT showed a significant improvement in glycemic levels in rats with OAGB in all time groups (p < 0.002, for all groups at 60 min). Insulin levels decreased significantly in all animals with OAGB, but glucagon levels increased (glucagon paradoxical response). GLP-1 and GIP increased in rats with OAGB at all times, but was only statistically significant in the early surgery group of GLP-1 (p < 0.005).

Conclusion

OAGB in a non-obese diabetic rat model improves glycemic control, with a significant decrease in glucose and insulin levels. This reduction without weight loss suggests a surgically induced enhancement of pancreatic function. It appears that this improvement occurs, although the GLP-1 levels were significantly increased only in the early stages. The paradoxical response of glucagon should be further evaluated.
Literatur
1.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014;37 Suppl 1:S14–80.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014;37 Suppl 1:S14–80.CrossRef
2.
Zurück zum Zitat Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.PubMedCrossRef Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.PubMedCrossRef
3.
4.
Zurück zum Zitat Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes. JAMA. 2008;299(3):341–3.PubMedCrossRef Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes. JAMA. 2008;299(3):341–3.PubMedCrossRef
5.
Zurück zum Zitat Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21:1194–6.CrossRef Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21:1194–6.CrossRef
6.
Zurück zum Zitat Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741–9.PubMedPubMedCentralCrossRef Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741–9.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405.PubMedCrossRef Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405.PubMedCrossRef
8.
Zurück zum Zitat Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80.PubMedCrossRef Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80.PubMedCrossRef
9.
Zurück zum Zitat Garcia-Caballero M, Carbajo M. One anastomosis gastric bypass: a simple, safe and efficient surgical procedure for treating morbid obesity. Nutr Hosp. 2004;19:372–5.PubMed Garcia-Caballero M, Carbajo M. One anastomosis gastric bypass: a simple, safe and efficient surgical procedure for treating morbid obesity. Nutr Hosp. 2004;19:372–5.PubMed
10.
Zurück zum Zitat Deitel M. Letter to the Editor: Bariatric surgery worldwide 2013 reveals a rise in mini gastric bypass. Obes Surg. 2015;25(11):2165.PubMedCrossRef Deitel M. Letter to the Editor: Bariatric surgery worldwide 2013 reveals a rise in mini gastric bypass. Obes Surg. 2015;25(11):2165.PubMedCrossRef
11.
Zurück zum Zitat Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52.PubMedCrossRef Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52.PubMedCrossRef
12.
Zurück zum Zitat Georgiadou D, Sergentanis TN, Nixon A, et al. Efficacy and safety of laparoscopic mini gastric bypass. A systematic review. Surg Obes Relat Dis. 2014;10(5):984–91.PubMedCrossRef Georgiadou D, Sergentanis TN, Nixon A, et al. Efficacy and safety of laparoscopic mini gastric bypass. A systematic review. Surg Obes Relat Dis. 2014;10(5):984–91.PubMedCrossRef
13.
Zurück zum Zitat Garcia-Caballero M, Valle M, Martinez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24–29 BMI patients with one anastomosis gastric bypass. Nutr Hosp. 2012;27(2):623–31.PubMed Garcia-Caballero M, Valle M, Martinez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24–29 BMI patients with one anastomosis gastric bypass. Nutr Hosp. 2012;27(2):623–31.PubMed
14.
Zurück zum Zitat Kular SK, Manchanda N, Cheema GK. Seven years of mini-gastric bypass in type II diabetes patients with body mass index <35 kg/m2. Obes Surg. 2015. doi:10.1007/s11695-015-1941-y. Kular SK, Manchanda N, Cheema GK. Seven years of mini-gastric bypass in type II diabetes patients with body mass index <35 kg/m2. Obes Surg. 2015. doi:10.​1007/​s11695-015-1941-y.
15.
Zurück zum Zitat Pacheco D, de Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg. 2007;194(2):221–4.PubMedCrossRef Pacheco D, de Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg. 2007;194(2):221–4.PubMedCrossRef
16.
Zurück zum Zitat Salinari S, le Roux CW, Bertuzzi A, et al. Duodenal–jejunal bypass and jejunectomy improve insulin sensitivity in Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion. Diabetes. 2014;63(3):1069–78.PubMedCrossRef Salinari S, le Roux CW, Bertuzzi A, et al. Duodenal–jejunal bypass and jejunectomy improve insulin sensitivity in Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion. Diabetes. 2014;63(3):1069–78.PubMedCrossRef
17.
Zurück zum Zitat Reis CE, Varez-Leite JI, Bressan J, et al. Role of bariatric–metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365–72.PubMedCrossRef Reis CE, Varez-Leite JI, Bressan J, et al. Role of bariatric–metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365–72.PubMedCrossRef
18.
Zurück zum Zitat Rubino F, Marescaux J. Effect of duodena–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1–11.PubMedPubMedCentralCrossRef Rubino F, Marescaux J. Effect of duodena–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1–11.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Speck M, Cho YM, Asadi A, et al. Duodenal–jejunal bypass protects GK rats from beta-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. Am J Physiol Endocrinol Metab. 2011;300(5):E923–32.PubMedCrossRef Speck M, Cho YM, Asadi A, et al. Duodenal–jejunal bypass protects GK rats from beta-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. Am J Physiol Endocrinol Metab. 2011;300(5):E923–32.PubMedCrossRef
20.
Zurück zum Zitat Le Roux CW, Dixon JB. Metabolic syndrome and type 2 diabetes: GLP-1 and other incretins. In: Deitel M, Gagner M, Dixon JB, Himpens J, Madan AK, editors. Handbook of obesity surgery. Toronto: FD Communications; 2010. p. 298–303. Le Roux CW, Dixon JB. Metabolic syndrome and type 2 diabetes: GLP-1 and other incretins. In: Deitel M, Gagner M, Dixon JB, Himpens J, Madan AK, editors. Handbook of obesity surgery. Toronto: FD Communications; 2010. p. 298–303.
21.
Zurück zum Zitat Zou ZD, Jiao YB, Wang YB, et al. Comparative effects of Roux-en-Y gastric bypass procedures preserving different gastric volume on blood glucose in Goto-Kakizaki rats. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15(1):39–42.PubMed Zou ZD, Jiao YB, Wang YB, et al. Comparative effects of Roux-en-Y gastric bypass procedures preserving different gastric volume on blood glucose in Goto-Kakizaki rats. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15(1):39–42.PubMed
22.
Zurück zum Zitat Portha B, Giroix MH, Tourrel-Cuzin C, et al. The GK rat: a prototype for the study of non-overweight type 2 diabetes. Methods Mol Biol. 2012;933:125–59.PubMed Portha B, Giroix MH, Tourrel-Cuzin C, et al. The GK rat: a prototype for the study of non-overweight type 2 diabetes. Methods Mol Biol. 2012;933:125–59.PubMed
24.
Zurück zum Zitat Corkey BE. Diabetes. Hyperinsulinemia: cause or consequence? Banting Lecture 2011. Diabetes. 2012;61(1):4–13.PubMedCrossRef Corkey BE. Diabetes. Hyperinsulinemia: cause or consequence? Banting Lecture 2011. Diabetes. 2012;61(1):4–13.PubMedCrossRef
25.
Zurück zum Zitat Pories WJ, Dohm GL. Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care. 2012;35(12):2438–42.PubMedPubMedCentralCrossRef Pories WJ, Dohm GL. Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care. 2012;35(12):2438–42.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(7):2479–85.PubMedPubMedCentralCrossRef Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(7):2479–85.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Bose M, Olivan B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg. 2009;19(2):217–29.PubMedCrossRef Bose M, Olivan B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg. 2009;19(2):217–29.PubMedCrossRef
28.
Zurück zum Zitat Mingrone G. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis. 2008;18(8):574–9.PubMedCrossRef Mingrone G. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis. 2008;18(8):574–9.PubMedCrossRef
29.
Zurück zum Zitat Vidal J, Jimenez A. Diabetes remission following metabolic surgery: is GLP-1 the culprit? Curr Atheroscler Rep. 2013;15(10):1–7.CrossRef Vidal J, Jimenez A. Diabetes remission following metabolic surgery: is GLP-1 the culprit? Curr Atheroscler Rep. 2013;15(10):1–7.CrossRef
Metadaten
Titel
The Effects of One-Anastomosis Gastric Bypass on Glucose Metabolism in Goto-Kakizaki Rats
verfasst von
Lorea Zubiaga
Rafael Abad
Jaime Ruiz-Tovar
Pablo Enriquez
Juan Antonio Vílchez
Mireia Calzada
José Antonio Pérez De Gracia
Mervyn Deitel
Publikationsdatum
17.03.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 11/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2138-8

Weitere Artikel der Ausgabe 11/2016

Obesity Surgery 11/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.